Archive for the ‘Psychological Aspects’ Category

Acute Psychosis After COVID Shot, Moderna Booster Singled Out for Chronic Hives, Merck COVID Drug Linked to New Virus Mutations

https://petermcculloughmd.substack.com/p/acute-psychosis-after-covid-19-vaccination

Acute Psychosis after COVID-19 Vaccination

Alarming Manuscripts Report Acute Neuropsychiatric Symptoms

By Peter A. McCullough, MD, MPH

Unvaccinated patients have mentioned half-jokingly that COVID-19 vaccination in friends and family makes some of them “crazy.” While I have always brushed this off as fear driven vaccine ideology taking over common sense in some zealots, the building literature on neuropsychiatric symptoms is alarming. There are now ~10 papers describing headache, fever, and a range of acute neuropsychiatric symptoms after both mRNA and adenoviral COVID-19 vaccination. The strong bias among editors and publishers has kept countless papers out of the mainstream medical media, hence one has to look far and wide to find information on the topic of vaccine safety. Borovina et al, from Croatia described three cases of acute headache followed by psychosis.  (See link for article and study)

_______________

Important excerpt:

One of the cases progressed to attempted suicide with a knife stabbing to the abdomen requiring emergency abdominal surgery.

As a doctor I am disturbed by medical evidence demonstrating gene coded SARS-CoV-2 Wuhan Institute of Virology Spike protein in the human brain after vaccination. I wonder how many subtle changes go clinically unrecognized.

McCullough rightly states that every suicide after Dec. 2020 should be investigated and the brand, doses, and dates of “vaccination” should be recorded and noted.  Unfortunately, none of this will happen.  It’s all #ABV (anything but the vaccine).

For more:

_________________

https://www.medpagetoday.com/infectiousdisease/covid19vaccine/102923

Moderna Booster Vaccine Singled Out for Chronic Hives

— Chronic spontaneous urticaria more frequent when compared with Pfizer’s mRNA vaccine
A photo of a vial of the Spikevax COVID vaccine

The monovalent Moderna COVID-19 booster vaccine may be associated with an elevated risk for new-onset chronic spontaneous urticaria (CSU), or hives lasting more than 6 weeks, according to a Swiss study.

Among people who got an mRNA COVID vaccine booster and had new-onset hives reported to local allergists, 90% had vaccination precede CSU in the canton of Vaud during the study period, as did 81% of patients in the nationwide cohort, reported Yannick Daniel Muller, MD, PhD, of the University of Lausanne in Switzerland, and coauthors.  (See link for article)

_______________

**Comment**

Predictably, the authors still want everyone to get “vaccinated,” and take the safe route by stating more research is needed.  They state that Moderna shots contain higher doses of mRNA and are more immunogenic than Pfizer shots, although both are clearly linked to a multitude of adverse events and death. The Vaccine advisory committee unanimously endorsed the FDA’s plan to harmonize the primary and booster shots to contain a bivalent composition with components targeting BA.4/5 and the original SARS-CoV-2 strain, eliminating the original monovalent productsBoth are deplorable and useless.

________________

https://www.bloomberg.com/news/articles/2023-02-01/merck-s-mrk-covid-drug-linked-to-viable-spreading-mutants-study-says

Merck Covid Drug Linked to New Virus Mutations, Study Says

  • So far, new versions aren’t more lethal, immune-evasive
  • Merck disputes study’s claim, says drug is ‘valuable’
Lagevrio
Lagevrio  Photographer: Donato Fasano/Getty Images
Article Summary:
  • Preprint study found here
  • The study points out the risk of trying to alter the pathogen’s genetic code
  • The study found that the medication molnupiravir (Lagevrio) is giving rise to new mutations in some patients which has some researchers worried the drug may create more contagious or dangerous variations of COVID
  • One author of the study states the drug should be discontinued due to the risks

No Testing Required to Get Paxlovid & Molnupiravir/Lagevrio, Even Though They Are Dangerous

But in a slick move, the FDA has removed COVID testing requirements to make it even easier to obtain Pfizer (Paxlovid) and Merck (Molnupiravir/Lagevrio) COVID treatments.  Now, exposed individuals with signs and symptoms (that look like any other flu-bug), can simply waltz into their doctor’s office and be diagnosed with COVID, even if they have a negative test result: however, they still can not obtain cheap, safe, effective drugs like ivermectin, HCQ, or even vitamin C.

And low and behold, a new study finds that ivermectin is a promising cancer drug.

This should tell you everything you need to know.

Abstract

Ivermectin is a widely used antiparasitic drug and shows promising anticancer activity in various cancer types. Although multiple signaling pathways modulated by ivermectin have been identified in tumor cells, few studies have focused on the exact target of ivermectin. Herein, we report the pharmacological effects and targets of ivermectin in prostate cancer. Ivermectin caused G0/G1 cell cycle arrest, induced cell apoptosis and DNA damage, and decreased androgen receptor (AR) signaling in prostate cancer cells. Further in vivo analysis showed ivermectin could suppress 22RV1 xenograft progression. Using integrated omics profiling, including RNA-seq and thermal proteome profiling, the forkhead box protein A1 (FOXA1) and non-homologous end joining (NHEJ) repair executer Ku70/Ku80 were strongly suggested as direct targets of ivermectin in prostate cancer. The interaction of ivermectin and FOXA1 reduced the chromatin accessibility of AR signaling and the G0/G1 cell cycle regulator E2F1, leading to cell proliferation inhibition. The interaction of ivermectin and Ku70/Ku80 impaired the NHEJ repair ability. Cooperating with the downregulation of homologous recombination repair ability after AR signaling inhibition, ivermectin increased intracellular DNA double-strand breaks and finally triggered cell death. Our findings demonstrate the anticancer effect of ivermectin in prostate cancer, indicating that its use may be a new therapeutic approach for prostate cancer.

Well now, ‘the powers that be’ simply can not have this.
Better censor and ban it off the face of the earth.

Post-Treatment Lyme Disease Syndrome & Language Fluency Deficits

https://academic.oup.com/acn/advance-article-abstract/doi/10.1093/arclin/acac095/6955887?

Language Fluency Deficits in Post-treatment Lyme Disease Syndrome

Archives of Clinical Neuropsychology, acac095, https://doi.org/10.1093/arclin/acac095
Published:  22 December 2022

 

Abstract
Objective

Recent neurocognitive studies of patients with post-treatment Lyme disease syndrome (PTLDS) find consistent deficits in memory and processing speed. Language fluency deficits are observed as well but may be secondary to poor memory and slowing rather than an independent deficit.

Method

This study performed a secondary analysis of data presented previously, including individuals with PTLDS and comparison samples of healthy volunteers (HC) and patients with major depressive disorder (MDD), to determine if language fluency deficits could be accounted for by poor performance in these other neurocognitive domains.

Results

Basic verbal abilities, memory, and processing speed were all significantly associated with fluency performance. MDD patients’ fluency deficits relative to HC were accounted for by these covariates. However, PTLDS patients’ poorer fluency performance relative to both other groups was not.

Ischemic Stroke With Hemorrhagic Conversion in a Case of Lyme Neuroborreliosis

https://www.cureus.com/articles/97069-ischemic-stroke-with-hemorrhagic-conversion-in-a-case-of-lyme-neuroborreliosis

Ischemic Stroke With Hemorrhagic Conversion in a Case of Lyme Neuroborreliosis



Abstract

Lyme disease is an infectious tick-borne illness predominant in northeastern and midwestern United States. The clinical presentation varies significantly and only a few cases develop Lyme neuroborreliosis (LNB), which makes diagnosis difficult. A 59-year-old male visiting from Michigan presented to a hospital in Florida with an ischemic stroke with aphasia and acute confusion for two days. He had imaging that noted a subacute infarct in the left parietal lobe along with multiple areas of white matter signal abnormalities and CSF serology positive for Borrelia burgdorferi IgM and IgG antibodies. The patient was placed on ceftriaxone for 30 days and showed significant clinical improvement. We present a case of ischemic stroke with hemorrhagic conversion and an incidental finding of LNB.

_________________

**Comment**

There is no way on earth that only a few cases develop Lyme neuroborrliosisThis statement shows the researcher’s complete disconnect from reality.

Testing is so abysmal, thousands fall through the diagnostic crack.  Then, if they manage to win the lottery and test positive, they are told it’s a “false positive,” and to “go home and be well.”

This patient in fact did win the lottery and managed to get diagnosed in Florida, which like all Southern states has had to fight tooth and nail to get public health to even recognize it.  And that probably wouldn’t have happened if it weren’t for infected researcher, Kerry Clark, who is finding Southern borrelia strains that will never be picked up in a million years using current CDC two-tier testing.  He also showed DNA of Bbsl in Lone Star ticks which might be a bridge vector of transmission to humans, but is still considered by ‘the powers that be’ to not transmit Lyme disease.  Instead, infected Southerners have been told they have STARI, a disease that looks, acts, and smells just like Lyme.

This patient, despite showing significant improvement, requires follow-up which will never happen.  If and when symptoms reappear he will simply be told it’s all “in his head.”

What It’s Like To Live With Brain Fog

https://www.lymedisease.org/what-its-like-with-brain-fog/

What it’s like to live with brain fog

By Lindsey Bever, Washington Post

Haze. Slow. Drunk. Lost. These are the words some people use to describe “brain fog.”

The condition, a form of cognitive dysfunction, has been plaguing people with certain chronic illnesses for years. But now, a new wave of people with long covid are experiencing it, casting a spotlight on the often debilitating condition.

“It’s a moment where the public and the medical community are realizing that this is real. This is what happens after certain infections,” said Akiko Iwasaki, a professor of immunobiology at Yale University and a co-author of a review article on covid-19-related cognitive impairment.

READ MORE

_______________

**Comment**

Long before COVID even existed, Lyme/MSIDS patients have suffered for decades with brain fog.

Per usual, dealing with the underlying infections will either improve or ameliorate this condition all together.  Detoxing also helps as well as balancing hormones, supplementing for deficiencies, dealing with mold, MCAS, and/or any other issue that is negatively affecting the immune system.  Diet is key and certain foods alone can cause brain fog.

Like everything with Lyme/MSIDS, it’s complex.

The Real Agenda Behind the American Academy of Pediatrics: Weaponizing Children’s Mental Health and Vaccines for Profit

https://childrenshealthdefense.org/defender/profit-american-academy-pediatrics-childrens-mental-health-vaccines/

The Real Agenda Behind American Academy of Pediatrics: Weaponizing Children’s Mental Health and Vaccines for Profit

With a budget of more than $127 million and a staff of 475, the American Academy of Pediatrics functions as a corporate and government mouthpiece that touts the wares of drug, vaccine and formula manufacturers.

As of 2019, roughly 72,000 physicians were actively working in pediatrics or pediatric subspecialties in the U.S., many of them members of the American Academy of Pediatrics (AAP).

Nominally, the AAP is a professional medical association (PMA), but more often than not, it functions as a corporate and government mouthpiece, including issuing policy guidance to its members stating that it is an “acceptable option to pediatric care clinicians to dismiss families who refuse vaccines.”

With total “revenue, gains and other support” amounting in 2022 to nearly $127 million — supporting a staff of 475 and a self-described role as the “#1 publisher of pediatric titles in the world” — the deep-pocketed AAP’s ability to broadcast policies desired by the Centers for Disease Control and Prevention (CDC) and tout the wares of drug, vaccine and formula manufacturers is significant.

That the AAP’s megaphone is one-sided has long attracted the notice of critics, who point to the organization’s “preference for fashionable political positions over evidence-based medicine” and its pattern of “play[ing] both sides of the street” — with its “‘trusted’ medical advice” issued in the context of generous funding from agenda-setting foundations, corporations and government agencies.

Even in a study that the AAP itself published, which examined pediatric PMA transparency and compliance with best practice guidelines, the AAP got middling marks for both, despite benefiting from “a significantly higher average budget” compared to sister organizations that earned better scores.

Currently, the AAP is using its bully pulpit to hammer home messages about vaccination — especially COVID-19 shots — and about an AAP-fashioned children’s mental health crisis.

Plainly, both issues have the potential to be highly profitable for the drug companies that festoon the AAP’s list of top-tier donors. But the organization also appears to be on board with a more subterranean aim — weaponizing vaccination and mental health to achieve more “brave new world” control over children’s bodies and minds.

Presidential grandstanding

Throughout 2022, the AAP’s soon-to-be-outgoing president, UCLA professor Dr. Moira Szilagyi, Ph.D., was an obedient foot soldier on both the vaccination and mental health fronts.

Szilagyi was voted the AAP’s 2022 president-elect in June 2020, and throughout the pandemic, she shamelessly brandished her status as a grandmother to peddle pediatric COVID-19 shots.

In October 2021 — not long before stepping into the AAP presidency — Szilagyi opined in a CNN piece titled “Pediatrician: What I want this Covid vaccine to do for my grandchildren” that the data from the vaccine clinical trials in younger children were “very reassuring.”

But, she confessed, she felt an “undercurrent of anxiety” over the fact that her masked grandchildren, at ages 5 and 8, did not yet have access to “the best protection of all: vaccination.”

Barely a month later, the CDC’s advisors overrode concerns about Pfizer’s clinical data to unanimously endorse the jab for Szilagyi’s grandchildren and others in their age group.

In June 2022, under Szilagyi’s stewardship, the AAP issued an enthusiastic press release applauding the CDC’s recommendation of “safe, effective COVID-19 vaccines” for babies as young as 6 months old.

In October, Szilagyi even wrote to White House COVID-19 Response Coordinator Ashish Jha to plead for reducing “the burdens of administering COVID-19 vaccines” to children, stating, “The nation’s pediatricians need to be supported as we attempt to vaccinate our nation’s youngest citizens against COVID-19.”

In that letter, Szilagyi — seemingly oblivious to the thousands of injuries and dozens of deaths already reported in children and adolescents who received COVID-19 jabs — expressed gratitude for babies’ and toddlers’ “access” to the shots and celebrated the imminent authorization of bivalent booster shots for kids.

In November, Szilagyi again took to CNN — this time trotting out her “heartbroken” feelings about crowded pediatric hospital wards and offering parents “reassurance” and the “advice” to get the whole family vaccinated for both influenza and COVID-19, “including boosters.”

Her actions over the past year also illustrated the AAP’s servile and co-dependent relationship with the CDC in other ways.

In 2017, BMJ editor Peter Doshi reported that the CDC is one of the AAP’s “steady funders”; from 2009 through 2016, the CDC shoveled $20 million in the AAP’s direction.

Returning the favor, Szilagyi testified in May 2022 before the House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies, making a case for more than $746 million in new CDC and Health Resources and Services Administration funding for the AAP’s pet causes — not all of which even concern American children.

For example, lamenting “pandemic-related disruptions” to routine childhood vaccination overseas, Szilagyi called for nearly half (48%) of the proposed funding ($356 million) to be routed to the CDC’s Global Immunization division.

Szilagyi lobbied for another hefty $205 million (28%) for the CDC’s National Center on Birth Defects and Developmental Disabilities (NCBDDD), the center that is supposed to be “search[ing] for the causes of autism” but which consistently denies any vaccine-autism connection.

CDC’s current NCBDDD director, Karen Remley, was a recent AAP CEO (2015-2018). Her predecessor at the NCBDDD’s helm (until retiring in January 2020) was Coleen Boyle, known for her early-career cover-up of Agent Orange and dioxin toxicity and later, for helping cement the fiction that vaccines have nothing to do with developmental disabilities.

Also on Szilagyi’s funding priorities list was a smaller request ($12 million) to study “sudden unexpected” infant and childhood deaths, another outcome with a probable — though AAP- and CDC-denied — link to vaccination.

The mental health dragnet

Szilagyi has a lengthy history of engagement with “vulnerable children” in the U.S.’s corrupt and dysfunctional foster care system and likes to reference those credentials.

In June, after the AAP called for mental health screening for all children from birth through age 21, medical reporter Martha Rosenberg noted in The Defender that children in foster care (and other marginalized kids) are precisely the youth most at risk of overmedication with “lucrative and dangerous psychiatric drugs — some of which can cause suicide, especially in children.”

Additional risks of across-the-board depression screening, pointed out by psychiatric experts quoted by Rosenberg, include overdiagnosis, medicalization of the “normal” and “carelessly applied labels” that, once entered into databases, become impossible to shed.

Other critics, skeptical of the “supposed” mental health crisis in young people, agree on the need to “take care in widening the net of psychiatric surveillance” and argue for the promotion of resilience rather than the celebration of vulnerability.

They also point out how the “language of harm and trauma” can be harnessed for “political motives,” including using it to censor “undesirable ideas.”

Spelling out psychiatry’s long history of “acting as an instrument for psychological, social and political control,” psychiatrist Peter Breggin has noted:

“The contemporary widespread diagnosing of children is a subtler form of social control that suppresses children rather than providing them with what they need to fulfill their basic needs in the home, school and family. Instead of reforming our educational system and improving family life, we drug our children into more docile states.”

Mental health is lucrative, however. For example, in September, the AAP earned a cool $2 million from the mental health branch of the U.S. Department of Health and Human Services to develop resources focused on “social media and mental wellness.”

And in October, the AAP joined 100-plus other organizations in writing to the Biden administration to urge a “National Emergency Declaration in children’s mental health,” no doubt hoping for more millions to be sent their way to address the “emergency.”

In July, Szilagyi and co-authors laid some of the conceptual groundwork for a mental health dragnet in a paper published in the influential journal Health Affairs, titled “Combating A Crisis By Integrating Mental Health Services And Primary Care.”

Cloaking their arguments in the veneer of “whole-person care,” the authors made a case for more integration of “behavioral health” into primary care — claiming that up to half of “behavioral health disorders begin by age 14.”

Describing barriers to this approach, they noted the current difficulty of sharing patient information “across integrated care team members,” criticizing “overly restrictive interpretations of federal laws and regulations.”

Perhaps that is why the AAP’s president-elect for 2023 is a health informatics expert.

Dr. Sandy Chung, like Szilagyi, is bullish on mental health, framing it as a “long-simmering” problem that the pandemic merely helped catapult into the spotlight.

Chung’s curriculum vitae and professional biographies list her work in the areas of mental health, electronic health records, “data integration” and the creation of “a national registry of child health data” as some of her primary achievements, suggesting that she is on board for the type of pervasive mental health tracking and surveillance that is giving other child health experts the heebie-jeebies.

Unfilled positions and unfulfilled pediatricians

A June 2021 article in the AAP’s own journal Pediatrics outlined a somewhat dire outlook for the pediatric profession, noting, ironically, large vacancies in “developmental and behavioral pediatrics and adolescent and child psychiatry” as well as child neurology.

The author also noted fewer applicants and more unfilled pediatric residency positions, suggesting that “strategies to strengthen the pediatric applicant pool must include … understanding factors that impact the career decisions of trainees.”

Although a large proportion of pediatricians currently in practice appears to be generally copacetic with AAP policy positions — with half of pediatric offices reporting “a policy of dismissing families who won’t vaccinate their children” — that still leaves others whose opinion differs.

In fact, in a December 2020 article in Pediatrics, apparently published to let off a little steam, a trio of university-based authors scolded the AAP and its adherents for their stance on this issue, noting, “it is wrong for clinicians not to accept vaccine refusers because they want only compliant families” and characterizing this approach as “excessively paternalistic and inconsistent with patient- and family-centered care.”

A decade ago — cited by journalist Richard Gale in CounterPunch — pediatrician Ken Stoller described the CDC’s and AAP’s all-too-effective “propagandizing” on the topic of thimerosal in vaccines:

“Now we have a generation of pediatricians … who actually need to be deprogrammed to understand what the true nature of all the neuro-behavioral problems are that they confront without any understanding of etiology or potential interventions.”

Unfortunately, ominous trends like California’s recent legislation to take away the licenses of doctors who don’t toe the party line, and similar witch hunts against independent-thinking doctors in other states, do not bode well for future medical independence.

Nor can children and their parents hope for any help from the AAP, beholden as it is not just to Big Pharma and next-generation biopharmaceutical and “gene therapy” companies, but also to population-control-oriented foundations such as the Bill & Melinda Gates Foundation and the David & Lucile Packard Foundation, infant formula companies like the disgraced Abbott Nutrition and National Security Agency surveillance partner AT&T.

Gale’s 2012 conclusion still holds: The AAP

has failed to protect children from their greatest enemy — the pharmaceutical and chemical industrial complex. … [W]hen addressing the prevention of diseases that directly affect the medical industry, the AAP’s record is dismal.”